Multiple Sclerosis Clinical Trial

Evaluating Intervention Responsiveness in People With Multiple Sclerosis

Summary

The purpose is to see how multiple sclerosis (MS) is associated with strength and sensation using MRI, in persons with MS. The investigators will also see whether exercise can improve these symptoms for persons with MS.

View Full Description

Full Description

Multiple sclerosis (MS) is a chronic inflammatory disorder that damages myelin sheaths and axons in the brain and spinal cord. Within ten years of being diagnosed with MS, a majority of people will experience disability, most often walking impairments. The currently available pharmacologic treatments offer protection from new attacks but do not help with recovery; thus, in many cases the only hope for improvement, is through physical rehabilitation.

Rehabilitative interventions, such as progressive resistance training (PRT), have been shown to improve strength and sometimes walking in many individuals with MS. However, there are also many individuals who do not respond, which tends to be ignored in the literature. In addition, most intervention studies measure the primary impairment (e.g, strength) with little or no consideration for other impairments (e.g., sensory loss) and any effects on more complicated movements (e.g. standing, or changing direction). Since MS is so heterogeneous, it would be helpful to know which individuals are likely to benefit from rehabilitation.

Standard MS care uses MRI for diagnosis, identification of inflammatory lesions, and determination of treatment efficacy. Conventional rehabilitation relies on clinical judgment, rating scales and impairment measures to determine treatment efficacy. The investigators would like to understand how behavioral impairments and MRI findings relate to each other, and predict rehabilitation potential for people with MS. The investigators have previously shown that damage measured using tract specific MRI, specifically magnetization transfer (MTI) and diffusion tensor imaging (DTI), correlates with physical impairments in individuals with MS. Here the investigators propose to determine whether measures of clinical impairment and tract specific MRI can improve our ability to predict who will respond best to a PRT exercise intervention by improving functional movement. The investigators will perform a PRT intervention. The investigators will measure sensory and motor impairments and walking ability before and after the intervention. MRI will be done before treatment to assess the integrity of critical motor (corticospinal, CST) and sensory (dorsal column-medial lemniscus, DC-ML) tracts across the cervical spinal cord and brain. The investigators hypothesize that a combination of impairment measures and MRI measure will predict improvement in functional movement following three months of PRT.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Confirmed diagnosis of MS
If on immunomodulatory therapy, subjects have to have been on that therapy for at least 6 months prior to the start of the study.
Medically stable
Able to follow complex directions as determined by a score of less than or equal to 1 on a subset of questions taken from the NIH Stroke scale
Normal passive range of motion at the hips, knees, and ankles with minimum to no pain

Exclusion Criteria:

Evidence of other neurological deficit that could interfere, such as previous stroke or muscle disease
Congestive heart failure
MS exacerbation within 8 weeks of study start
MS exacerbation affecting CST or DC-ML tracts
peripheral artery disease with claudication
cancer
pulmonary or renal failure
unstable angina
uncontrolled hypertension (greater than 190/110 mmHg)
orthopedic or pain conditions
history of kidney disease, due to potential of gadolinium reactions leading to nephrogenic systemic fibrosis (NSF)
because pregnancy may change the MRI signals that we are studying, we have chosen not to enroll pregnant women in this study

Healthy controls have the same age and exclusion criteria as people with multiple sclerosis except that they must have normal neurological function

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT01632293

Recruitment Status:

Completed

Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Motion Analysis Lab
Baltimore Maryland, 21205, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT01632293

Recruitment Status:

Completed

Sponsor:


Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider